Cargando…
Multiple drugs: Exacerbation of myasthenia gravis following off-label use and COVID-19 infection: 3 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499004/ http://dx.doi.org/10.1007/s40278-020-83561-9 |
Ejemplares similares
-
Hydroxychloroquine: Aggravation of myasthenia gravis following off label use: case report
Publicado: (2020) -
Multiple drugs: Exacerbation of myasthenia gravis and lack of efficacy: 5 case reports
Publicado: (2022) -
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report
por: Singh, Shivangi, et al.
Publicado: (2020) -
The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
por: Seok, Hung Youl, et al.
Publicado: (2017) -
An Interesting Case Report of Myasthenia Gravis Exacerbation Induced by Durvalumab
por: Abidoye, Oluseyi, et al.
Publicado: (2022)